Stone Mountain Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
ClostraBio develops next-generation probiotics and a platform for delivering bacterial metabolites to support gut health, targeting inflammatory bowel disease (IBD) and food allergy.
BiotechDigital HealthHealthtechChicago, US
Jeffrey Hubbell(Secretary)Cathryn Nagler(President)inBrett Newswanger(Chief Operating Officer)
BoardJohn Flavin(Executive Chairman)in
PartnerJohn Diaz· solo GP
Co-investorsPortal Innovations
Leda provides self-administered DNA testing kits and related services for individuals who have experienced sexual assault, aiming to improve evidence collection and support for survivors.
HealthtechImpact & Social GoodBrooklyn, US
Liesel Vaidya(Executive Officer, Director)inMadison Campbell(Executive Officer, Director)in
PartnerJohn Diaz· solo GP
Co-investors2B.VCCalm/Storm VCGaingelsHelmHypothesisThe Innovation Space+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









__Twitter.png)

